United Kingdom · Series B startup

Who invested in Replimune

2 rounds we have observed, with the 8 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

BiotechHealthcare

Funding summaryUpdated 26 Oct 2026

$85Mraised across 2 rounds since 2015, from 2 sources

$30MSeries A$55MSeries B
Latest round
Series B, $55MSept 2017
Step-upi
1.8×
Investors
8
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20162017
$30MSeries A$55MSeries B
First round
Series A, $30M
Sept 2015
Biggest round
$55M
Series B · Sept 2017
Between rounds
23 months
from the last two

The rounds

  1. Sept 2017
    Series B$55M5 new2 returning

    Reported by FinSMEs

  2. Sept 2015
    Series A$30M3 new

    From a historical funding record

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Forbion Capital PartnersPrivate equity2rounds
Omega FundsVC firm2rounds
Atlas VentureVC firm1round
Redmile GroupVC firm1round
Cormorant CapitalVC firm1round
AtlasPrivate equity1round
Leerink PartnersGrowth equity1round
Foresite Capital/ Bainno record of our own yet1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Replimune

Who invested in Replimune?

Replimune's investors include Forbion Capital Partners, Omega Funds, Atlas Venture, Redmile Group and Cormorant Capital, and 3 more on record.

How much has Replimune raised?

Replimune has raised $85M across 2 rounds since 2015.

When did Replimune last raise?

Replimune's most recent round was a Series B of $55M in Sept 2017.

What was Replimune's biggest round?

Its most recent round, $55M in Sept 2017, is also its largest on record.

Who backed Replimune first?

Replimune's first round on record, in Sept 2015, was backed by Atlas Venture, Forbion Capital Partners and Omega Funds.

What stage is Replimune at?

Replimune's latest named round is a Series B, in Sept 2017.

Where is Replimune based?

Replimune is based in the United Kingdom.

Companies like Replimune

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.